全文获取类型
收费全文 | 5139篇 |
免费 | 155篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 93篇 |
妇产科学 | 1684篇 |
基础医学 | 296篇 |
口腔科学 | 78篇 |
临床医学 | 245篇 |
内科学 | 415篇 |
皮肤病学 | 715篇 |
神经病学 | 472篇 |
特种医学 | 272篇 |
外科学 | 442篇 |
综合类 | 41篇 |
预防医学 | 122篇 |
眼科学 | 18篇 |
药学 | 97篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 227篇 |
出版年
2015年 | 55篇 |
2014年 | 63篇 |
2013年 | 81篇 |
2012年 | 86篇 |
2011年 | 89篇 |
2010年 | 88篇 |
2009年 | 96篇 |
2008年 | 89篇 |
2007年 | 96篇 |
2006年 | 87篇 |
2005年 | 83篇 |
2004年 | 63篇 |
2003年 | 83篇 |
2002年 | 62篇 |
2001年 | 67篇 |
1999年 | 57篇 |
1998年 | 93篇 |
1997年 | 90篇 |
1996年 | 68篇 |
1995年 | 61篇 |
1993年 | 57篇 |
1989年 | 55篇 |
1987年 | 59篇 |
1975年 | 79篇 |
1973年 | 64篇 |
1971年 | 68篇 |
1969年 | 51篇 |
1967年 | 68篇 |
1965年 | 54篇 |
1964年 | 55篇 |
1963年 | 54篇 |
1961年 | 54篇 |
1959年 | 63篇 |
1957年 | 64篇 |
1955年 | 109篇 |
1954年 | 82篇 |
1942年 | 90篇 |
1938年 | 80篇 |
1936年 | 63篇 |
1933年 | 71篇 |
1931年 | 112篇 |
1930年 | 100篇 |
1929年 | 150篇 |
1928年 | 155篇 |
1927年 | 119篇 |
1926年 | 189篇 |
1925年 | 151篇 |
1924年 | 128篇 |
1923年 | 125篇 |
1922年 | 209篇 |
排序方式: 共有5315条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Pyomyositis: characteristics at CT and MR imaging 总被引:9,自引:0,他引:9
5.
6.
AJ Larner MRCP 《International journal of clinical practice》1994,48(5):272-274
SUMMARY A case is reported of pseudohyperphosphataemia in association with a monoclonal gammopathy of undetermined significance. 相似文献
7.
H W Herr W F Whitmore M J Morse P C Sogani P Russo W R Fair 《The Journal of urology》1990,144(5):1083-1088
The role of an operation in patients receiving neoadjuvant chemotherapy for clinically localized but invasive transitional cell carcinoma of the bladder currently is evolving. An operation is essential for case selection and evaluation of local response but it also contributes to bladder preservation and survival. The procedure that is necessary to select for and assess response to chemotherapy may itself alter the actual or proceed to evolution of invasive bladder cancer. Neoadjuvant chemotherapy is a reasonable therapeutic strategy in selected patients but it remains to be seen whether the results will prove to be superior to those achieved with standard endoscopic and open operations. 相似文献
8.
Surgical treatment of brain metastases from renal cell carcinoma 总被引:1,自引:0,他引:1
R A Badalament R W Gluck G Y Wong C Gnecco E Kreutzer H W Herr W R Fair J H Galicich 《Urology》1990,36(2):112-117
Between January 1976 and December 1986, 22 patients with renal cell carcinoma underwent surgical resection of brain metastases at Memorial Sloan-Kettering Cancer Center. Ten of the patients had metastases limited to the brain and 12 also had extracranial metastases. Twenty patients received external radiotherapy. Five had craniotomy after failing radiation therapy and 15 had adjuvant radiotherapy. Two patients died within thirty days following craniotomy; the median survival of the remaining 20 patients was 20.9 +/- 6.8 months calculated according to a Weibull survival model. Variables examined in relation to survival included absence or presence of extracranial metastases at time of craniotomy, time interval between nephrectomy and diagnosis of cerebral metastases, neurologic status prior to craniotomy, location of the brain tumor, and patient age. None of the variables was significant at the 10 percent level by the Weibull analysis. However, three favorable prognostic factors, namely metachronous brain metastasis more than one year after nephrectomy, minimal or no neurologic deficit at time of craniotomy, and infratentorial lesions show a trend toward improved survival with p less than 0.20. The data suggest that surgical resection of a single and occasionally multiple brain metastases is warranted in selected patients with renal cell carcinoma. 相似文献
9.
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma 总被引:1,自引:0,他引:1
P Russo G Liguori W D Heston R Huryk C R Yang W R Fair W F Whitmore H W Herr 《Cancer research》1987,47(22):5967-5970
Clinical trials have utilized intermittent diethylstilbestrol diphosphate (DES) therapy in advanced symptomatic prostatic carcinoma to diminish the morbidity of standard endocrine therapy. To determine the effect of intermittent DES administration on the Dunning R3327 rat prostatic adenocarcinoma 60 days following tumor implant, 6 groups were randomly assigned: control (N = 8), castrate (N = 10), high dose DES (N = 8, 1.6 micrograms/ml DES continuously in drinking water), low dose DES (N = 10, 0.4 microgram/ml continuously in drinking water), intermittent high dose DES (N = 10, 1.6 micrograms/ml DES in drinking water for 1 week, then off for 3 weeks), and intermittent low dose DES (N = 10, 0.4 microgram/ml DES for 1 week, then off for 3 weeks). Results indicate that low or high dose DES, and intermittent low or intermittent high dose DES during the week of administration were able to reduce serum testosterone to castrate levels (0.1 ng/ml). After withdrawal of intermittent DES, serum testosterone returned toward control levels (1.0 ng/ml). Initial mean tumor burden between control and treatment groups was not significantly different. All DES exposed rats had a tumor volume at death (range, 15.6-18.3 cm3) smaller than control (mean, 25.4 cm3) or castrate (mean, 40.8 cm3) rats. Despite this significant survival advantage from the time of randomization was achieved only in castrate (median survival, 331 days) or high dose DES (median survival, 359 days) groups compared to control (median survival, 225 days). Similarly, significant prolongation in tumor doubling time was achieved only by rats receiving castration or high dose DES. Intermittent DES administration controls tumor volume but does not provide a survival advantage. In this respect, intermittent DES is inferior to castration. 相似文献
10.